Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.

The African Region is committed to measles elimination by 2020 but coverage with the first dose of measles-containing vaccine was only 70% in 2017. Several obstacles to achieving high coverage with measles and rubella vaccines exist, some of which could be overcome with new vaccine delivery technologies. Microarray array patches (MAPs) are single-dose devices used for transcutaneous administration of molecules, including inactivated or attenuated vaccines, that penetrate the outer stratum corneum of the skin, delivering antigens to the epidermis or dermis.

Building Capacity for Cyberbiosecurity Training.

Cyberbiosecurity lies at the intersection of cybersecurity and biosecurity and addresses the protection of valuable biological material and associated information. As an emerging concept, cyberbiosecurity requires the integration of training strategies targeted to both current and future professionals; as well as an increased awareness in the wider stakeholder community. As the discrete discipline of cyberbiosecurity continues to develop, initial training efforts are likely to include workshops and specialized training that bridge the disciplines of information technology (IT) and life sciences.

Cyberbiosecurity: A Call for Cooperation in a New Threat Landscape.

The life sciences now interface broadly with information technology (IT) and cybersecurity. This convergence is a key driver in the explosion of biotechnology research and its industrial applications in health care, agriculture, manufacturing, automation, artificial intelligence, and synthetic biology. As the information and handling mechanisms for biological materials have become increasingly digitized, many market sectors are now vulnerable to threats at the digital interface.